March 2, 2026 NAION Warning In the U.K., the Medicines and Healthcare products Regulatory Agency has issued a safety update warning that semaglutide, the widely used diabetes and weight loss drug sold as Wegovy, Ozempic and Rybelsus, may be linked in rare cases to a serious eye condition that can cause sudden vision loss
GLP-1 agonists are a class of medications traditionally prescribed for managing type 2 diabetes
Metabolic and glucose regulation : Berberine has been studied for its effects on blood glucose control, with some research suggesting it may improve insulin sensitivity and reduce fasting blood glucose levels through AMPK activation
Anabolic androgenic steroidinduced hypogonadism, a reversible condition in male individuals
Contains: 4 x 0.5 mL Single-dose Prefilled Syringes Push to open Package/Label Display Panel 0.5 mg/0.5 mL Syringe NDC XXXX-XXXX-XX List XXXXXX Ozempic 0.5 mg (semaglutide) injection 0.5 mg/0.5 mL Use Ozempic 1 time a week For subcutaneous use only Each prefilled syringe delivers 0.5 mg semaglutide Rx only Dispense the enclosed Medication Guide to each patient